The IBN SINA Pharmaceutical Industry (DHA:IBNSINA) LT-Debt-to-Total-Asset: 0.00 (As of . 20)


DHA:IBNSINA The IBN SINA Pharmaceutical Industry PLC DHA:IBNSINA
20 GF Score
Price BDT319.40
View Full Analysis

What is The IBN SINA Pharmaceutical Industry LT-Debt-to-Total-Asset?

The IBN SINA Pharmaceutical Industry DHA:IBNSINA +0.66% 20 LT-Debt-to-Total-Asset is 0.00 as of . 20. GuruFocus rates DHA:IBNSINA with a GF Score™ of 20/100.

LT Debt to Total Assets is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. It is calculated as a company's Long-Term Debt & Capital Lease Obligationdivide by its Total Assets. The IBN SINA Pharmaceutical Industry's long-term debt to total assests ratio for the quarter that ended in . 20 was 0.00.

The IBN SINA Pharmaceutical Industry's long-term debt to total assets ratio stayed the same from . 20 (0.00) to . 20 (0.00).

The IBN SINA Pharmaceutical Industry  (DHA:IBNSINA) LT-Debt-to-Total-Asset Explanation

LT Debt to Total Asset is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. A year-over-year decrease in this metric would suggest the company is progressively becoming less dependent on debt to grow their business.

The IBN SINA Pharmaceutical Industry LT-Debt-to-Total-Asset Related Terms

The IBN SINA Pharmaceutical Industry LT-Debt-to-Total-Asset Historical Data

* Premium members only.

The historical data trend for The IBN SINA Pharmaceutical Industry's LT-Debt-to-Total-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

The IBN SINA Pharmaceutical Industry LT-Debt-to-Total-Asset Chart

The IBN SINA Pharmaceutical Industry Annual Data
Trend
LT-Debt-to-Total-Asset

The IBN SINA Pharmaceutical Industry Semi-Annual Data
LT-Debt-to-Total-Asset
DHA:IBNSINA
20GF Score
The IBN SINA Pharmaceutical Industry PLC DHA:IBNSINA
LT-Debt-to-Total-Asset is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

The IBN SINA Pharmaceutical Industry LT-Debt-to-Total-Asset Calculation

The IBN SINA Pharmaceutical Industry's Long-Term Debt to Total Asset Ratio for the fiscal year that ended in . 20 is calculated as

LT Debt to Total Assets (A: . 20 )=Long-Term Debt & Capital Lease Obligation (A: . 20 )/Total Assets (A: . 20 )
=/
=

The IBN SINA Pharmaceutical Industry's Long-Term Debt to Total Asset Ratio for the quarter that ended in . 20 is calculated as

LT Debt to Total Assets (Q: . 20 )=Long-Term Debt & Capital Lease Obligation (Q: . 20 )/Total Assets (Q: . 20 )
=/
=

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about LT-Debt-to-Total-Asset →
What does a LT-Debt-to-Total-Asset of 0.00 mean?
The IBN SINA Pharmaceutical Industry (DHA:IBNSINA) has a LT-Debt-to-Total-Asset of 0.00 as of . 20. Long-term Debt to Total Asset ratio is the ratio of total long-term debt to total assets. View historical data on The IBN SINA Pharmaceutical Industry and its competitors.
Is The IBN SINA Pharmaceutical Industry's LT-Debt-to-Total-Asset too high?
The IBN SINA Pharmaceutical Industry's current LT-Debt-to-Total-Asset is 0.00. Overall, The IBN SINA Pharmaceutical Industry has a GF Score™ of 20/100, reflecting its overall financial health beyond just this single metric.
How does The IBN SINA Pharmaceutical Industry's LT-Debt-to-Total-Asset compare to IMNPQ?
The IBN SINA Pharmaceutical Industry's LT-Debt-to-Total-Asset of 0.00 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good LT-Debt-to-Total-Asset for a Drug Manufacturers company?
A good LT-Debt-to-Total-Asset depends on the Drug Manufacturers industry context. However, LT-Debt-to-Total-Asset should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high LT-Debt-to-Total-Asset mean?
A high LT-Debt-to-Total-Asset can signal that a stock is expensive relative to its fundamentals. Long-term Debt to Total Asset ratio is the ratio of total long-term debt to total assets. View historical data on The IBN SINA Pharmaceutical Industry and its competitors. The IBN SINA Pharmaceutical Industry's current LT-Debt-to-Total-Asset is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is The IBN SINA Pharmaceutical Industry stock overvalued right now?
The IBN SINA Pharmaceutical Industry (DHA:IBNSINA) has a current LT-Debt-to-Total-Asset of 0.00. The current LT-Debt-to-Total-Asset is 0.00. The IBN SINA Pharmaceutical Industry's overall GF Score™ is 20/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is LT-Debt-to-Total-Asset calculated?
LT-Debt-to-Total-Asset is calculated from a company's financial statements. For The IBN SINA Pharmaceutical Industry (DHA:IBNSINA), the current LT-Debt-to-Total-Asset is 0.00 as of . 20. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

The IBN SINA Pharmaceutical Industry Business Description

Address Mirpur Road, Tanin Center, 3 Asad Gate, Mohammadpur, Dhaka, BGD, 1207
The IBN SINA Pharmaceutical Industry PLC is engaged in the production and marketing of pharmaceutical drugs and natural medicines in both the local and international market.
20GF Score

Get the complete analysis for DHA:IBNSINA

LT-Debt-to-Total-Asset is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

BDT319.40
Price